I hate to say I dont know the future of this, but its exciting, but also I dont know how were going to get there
This happens either directly or with help from glutathione S-transferases (GSTs)
Immunogenicity: The FDA classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding (immunogenicity, impurities, and insufficient safety evidence for suggested administration routes)
Summary of key findings: In vitro: reduced oxidative stress, improved cell function
During the meeting, the FDAs own scientists recommended against allowing compounding pharmacies to produce any of the seven peptides being considered due to a lack of evidence showing they are safe and effective
High levels can reduce your risk of macular degeneration, a leading cause of blindness